Active	Status	Sponsor type	Region	Phase	Filter
5 Active 3 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ungerechts, Guy
NCT05733611: RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC	Active, not recruiting	2	4	US	RP2, RP3, atezolizumab, bevacizumab	Replimune Inc., Roche Pharma AG	Refractory Metastatic Colorectal Cancer, pMMR, MSS	01/27	03/27
Schmidt, Martina E
No trials found
Michel, Laura
No trials found